Catalio Capital Management, LP 13F Holdings
CIK 0001958125 · NEW YORK, NY
As of Sep 30, 2025, Catalio Capital Management, LP reported 38 positions worth $540.9M in its SEC Form 13F filing.
Top 25 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| ELI LILLY & CO | LLY | Healthcare | 57,376 | $43.8M | 8.09% |
| ABBVIE INC | ABBV | Equity | 154,834 | $35.9M | 6.63% |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 622,729 | $32.3M | 5.98% |
| INTUITIVE SURGICAL INC | ISRG | Healthcare | 71,343 | $31.9M | 5.90% |
| ASCENDIS PHARMA A | ASND | Healthcare | 144,954 | $28.8M | 5.33% |
| SOLENO THERAPEUTICS INC | SLNO | Healthcare | 418,245 | $28.3M | 5.23% |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 667,615 | $26.3M | 4.86% |
| BOSTON SCIENTIFIC CORP | BSX | Healthcare | 262,972 | $25.7M | 4.75% |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 1,614,717 | $24.8M | 4.59% |
| CYTOKINETICS INC | CYTK | Healthcare | 451,581 | $24.8M | 4.59% |
| NATERA INC | NTRA | Healthcare | 148,369 | $23.9M | 4.42% |
| REGENERON PHARMACEUTICALS INC | REGN | Healthcare | 35,344 |